Publications by authors named "Mark Paciga"

Claim this Profile
M
Macrophage-Derived Factors with the Potential to Contribute to the Pathogenicity of HIV-1 and HIV-2: Roles of M-CSF and CXCL7.
Chunling Gao, Joseph Kutza, Weiming Ouyang, Tobias A Grimm, Karen Fields, Mark Paciga

Int J Mol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage-Derived Factors with the Potential to Contribute to Pathogenicity of HIV-1 and HIV-2: Role of CCL-2/MCP-1.
Chunling Gao, Weiming Ouyang, Joseph Kutza, Tobias A Grimm, Karen Fields, Mark Paciga

Viruses· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.
Lee Pai-Scherf, Gideon M Blumenthal, Hongshan Li, Sriram Subramaniam, Pallavi S Mishra-Kalyani, Mark Paciga

Oncologist· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma.
Meredith K Chuk, Jennie T Chang, Marc R Theoret, Emmanuel Sampene, Kun He, Mark Paciga

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.
Tzanko S Stantchev, Mark Paciga, Carla R Lankford, Franziska Schwartzkopff, Christopher C Broder

Retrovirology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberoinfundibular Peptide of 39 residues is required for germ cell development.
Ted B Usdin, Mark Paciga, Tim Riordan, Jonathan Kuo, Alissa Parmelee

Endocrinology· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for cross-talk between stanniocalcins.
Mark Paciga, Kathi James, J Ryan J Gillespie, Graham F Wagner

Can J Physiol Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of big stanniocalcin variants in mammalian adipocytes and adrenocortical cells.
Mark Paciga, Edward R Hirvi, Kathi James, Graham F Wagner

Am J Physiol Endocrinol Metab· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of luteal cell big stanniocalcin production and secretion.
Mark Paciga, Gabriel E DiMattia, Graham F Wagner

Endocrinology· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of big stanniocalcin and its receptor to lipid storage droplets of ovarian steroidogenic cells.
Mark Paciga, Christopher R McCudden, Constantine Londos, Gabriel E DiMattia, Graham F Wagner

J Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian stanniocalcin is structurally unique in mammals and its production and release are regulated through the luteinizing hormone receptor.
Mark Paciga, Andrew J Watson, Gabriel E DiMattia, Graham F Wagner

Endocrinology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis